Investment
Features
FeesSafety
Academy
More
Pluang+

Compare 10X Genomics Inc (TXG) vs Vanguard Short Term Corporate Bond ETF (VCSH) Price & Performance

10X Genomics IncTrade
Vanguard Short Term Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

10X Genomics Inc vs Vanguard Short Term Corporate Bond ETF — how do they compare? 10X Genomics Inc trades at $59 (market cap $7.61B), while Vanguard Short Term Corporate Bond ETF trades at $78.52. The key difference: 10X Genomics Inc is trading nearer its 52-week high, Vanguard Short Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.

TXGVCSH
Market Cap
$7.61B
Sector
HealthFixed Income
52-Week High
$58.57$80.20
52-Week Low
$11.34$78.41
Enterprise Value
$7.14B

Returns comparison

Trailing returns across standard periods

About 10X Genomics Inc

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.

Read more on TXG

About Vanguard Short Term Corporate Bond ETF

VCSH tracks the Bloomberg U.S. 1-5 Year Corporate Bond Index, focusing on high-quality, investment-grade debt with short maturities. It is designed to offer higher income than Treasury bills with significantly lower interest rate sensitivity than intermediate or long-term bond funds.

Read more on VCSH